（编辑 姚尧） 证券日报网1月23日讯 ，博拓生物在接受调研者提问时表示，公司认为，脑机接口产业将会是未来医疗 大健康赛道中值得长期投资的产业，并将会成为公司在医疗器械领域的重要战略布局。随着我国政策工 业和信息化部等七部门联合印发的《关于推动脑机接口产业创新发展的实施意见》明确提出，到2027年 初步建立先进的技术体系、产业体系和标准体系，2030年培育2至3家有全球影响力的领军企业，为行业 发展提供了明确指引。公司早在2023年对脑机接口方向就有研究和探索，并于2025年战略入股杭州青石 永隽，成功切入侵入式脑机接口重度难治性抑郁症治疗领域，此次参股皓世天辉则进一步完善了公司在 脑机接口领域抑郁及焦虑症等方向的检测和治疗布局。今后，公司将继续坚定在脑机接口领域的战略布 局规划，一方面公司通过旗下产投平台以自有资金进行参股或并购等方式深度参与脑机接口产业，赋能 被投企业加速产品产业及商业化进程，构建公司协同发展的医疗健康生态链；另一方面，公司拟通过设 立脑机接口产业基金，借助专业投资机构的力量及资源优势，加快推动公司在脑机接口、脑神经科学领 域的产业链布局。 ...

Core Viewpoint - Aipeng Medical (300753.SZ) has signed a partnership agreement to invest in a fund focused on brain-computer interfaces, neuroscience, and mental health, aiming to optimize its industry layout and leverage professional investment resources [1] Group 1: Investment Details - Aipeng Medical will invest RMB 49.7 million as a limited partner, representing a 49.7% stake in the investment fund [1] - The investment is directed towards sectors including brain-computer interfaces, neuroscience, mental health disorders, and other healthcare areas [1] Group 2: Strategic Objectives - The investment aims to accelerate the optimization of the company's industrial layout while ensuring that daily operations and development are not affected [1] - The partnership is designed to effectively control investment risks while leveraging the strengths of professional investment institutions [1]

Core Viewpoint - Aipeng Medical (300753.SZ) has signed a partnership agreement to invest in a fund focused on brain-computer interfaces, neuroscience, and mental health, aiming to optimize its industry layout and leverage professional investment resources [1] Group 1: Investment Details - Aipeng Medical will invest RMB 49.7 million as a limited partner, representing a 49.7% stake in the investment fund [1] - The investment is directed towards sectors including brain-computer interfaces, neuroscience, mental health disorders, and other healthcare areas [1] Group 2: Strategic Objectives - The investment aims to accelerate the optimization of the company's industrial layout while ensuring that daily operations and development are not affected [1] - The partnership is designed to effectively control investment risks while leveraging the strengths of professional investment institutions [1]

Group 1 - The company announced a joint investment with Jiangsu Yingjue Private Equity Fund Management Co., Ltd. and Jiaxing Silin Venture Capital Partnership to establish Aipeng Zhilian Cloud Brain (Jiaxing) Equity Investment Partnership [1] - The company will act as a limited partner, contributing RMB 49.7 million, which represents a 49.7% stake in the investment fund [1] - The fund will primarily focus on equity investments in areas such as brain-computer interfaces, neuroscience, mental system diseases, and other healthcare sectors, with an investment period of 4 years and a total duration of 7 years [1]